Plans for the partnership for radiation therapy company ViewRay with Medtronic and Elekta are in the works. News of the new joint decision has already increased ViewRay shares up 37% in the after-hours trading. The agreement is however contingent upon ViewRay raising $75 million in equity capital, so the agreement is non-binding at the time. The collaboration is hopeful for ViewRay to work with Elekta and run clinical studies to research MR-guided radiation therapy. The details of the agreement made with Medtronic are less available in this stage, but analysts believe the investments from Medtronic’s partnership show “strong signs”. To read more on this new partnership with these companies read here.